GGrantIndex
← Search

Targeted Clinical Trials for Antimicrobial Resistance

$3,797,027N01FY2014AINIH

Duke University, Durham NC

Investigators

Abstract

To evaluate strategies that test the safety and effectiveness of therapeutic approaches/regimens to reduce the probability of the emergence of antibiotic drug resistance by minimizing unnecessary drug exposure. Trial title: A Multi-Center, Randomized, Open-Label, Comparative Study to Assess the Safety and Efficacy of a Treatment Algorithm to Reduce the Use of Vancomycin in Adult Patients With Blood Stream Infections Due to Staphylococci.

View original record on NIH RePORTER →